Forming new connections: Advances in human stem-cell-derived interneuron therapy for treating epilepsy
Jyoti Gupta1, Janice R Naegele2
1Department of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Neuron
|March 16, 2023
Summary
Human stem cell-derived interneurons show promise for treating epilepsy. These cells effectively suppressed seizures for up to nine months in a study, offering new hope for temporal lobe epilepsy patients.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Epilepsy Research
Background:
- Temporal lobe epilepsy (TLE) is characterized by network hyperexcitability.
- Inhibitory interneurons play a crucial role in regulating neuronal activity.
- Replacing lost or dysfunctional interneurons is a potential therapeutic strategy for TLE.
Purpose of the Study:
- To evaluate the long-term efficacy of human pluripotent stem cell (hPSC)-derived inhibitory interneurons in a model of TLE.
- To assess the potential of these cells to correct network hyperexcitability and reduce seizure frequency.
Main Methods:
- Generation of inhibitory interneuron progenitors from hPSCs.
- Transplantation of hPSC-derived interneurons into an epileptic host circuitry.
- Long-term monitoring of seizure activity and interneuron integration post-transplantation.
Main Results:
- Robust seizure suppression was observed up to nine months post-transplantation.
- hPSC-derived interneurons successfully integrated into the host epileptic circuitry.
- The duration of seizure suppression significantly exceeded previously observed timeframes.
Conclusions:
- hPSC-derived interneurons offer a promising cell-based therapy for TLE.
- Long-term engraftment and functional integration of transplanted interneurons can lead to sustained seizure control.
- This approach holds potential for correcting network hyperexcitability in epilepsy.
More Related Videos
Related Concept Videos
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K